IREN
IREN Limited
There isn't enough reported data to score IREN yet.
SBSI
Southside Bancshares, Inc.
SBSI's fundamentals are strong: its operating margin rose 8 points to 43% and revenue grew 16%. At 11x earnings, it's trading below its usual 12x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
SBSI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
SBSI's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like SBSI.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
SBSI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $32.86 | -6% |
| Forward | 10x | $34.98 | — |
| Current | 11x | $34.98 | — |
| Fair | 12x | $39.16 | +12% |
| Expensive | 15x | $48.19 | +38% |
Historical ranges are pointers, not guarantees.
SBSI's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SBSI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
SBSI has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
SBSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.51 | +6% |
| Q3 2026 | $3.31 | +44% |
| Q2 2026 | $2.54 | -9.9% |
| Q1 2026 | $2.36 | -19% |
| Q4 2025 | $2.29 | -21% |
| Q3 2025 | $2.30 | -17% |
| Q2 2025 | $2.82 | +4.4% |
| Q1 2025 | $2.91 | +7.8% |
| Q4 2024 | $2.91 | +3.2% |
SBSI has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
SBSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $74M | +69% |
| Q2 2026 | $71.3M | +7.4% |
| Q1 2026 | $70.3M | +9.7% |
| Q4 2025 | $62.8M | -4.8% |
| Q3 2025 | $43.7M | -31% |
| Q2 2025 | $66.4M | +1.9% |
| Q1 2025 | $64.1M | +1.6% |
| Q4 2024 | $66M | +16% |
SBSI's revenue is growing: $74M last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 46% | +35 points |
| Q2 2026 | 46% | +5.7 points |
| Q1 2026 | 40% | -0.7 points |
| Q4 2025 | 39% | -0.7 points |
| Q3 2025 | 12% | -28 points |
| Q2 2025 | 40% | -5.9 points |
| Q1 2025 | 41% | -0.5 points |
| Q4 2024 | 40% | +5.8 points |
SBSI has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
SBSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $65.4M | +75% |
| Q2 2026 | $27.5M | +$29.5M |
| Q1 2026 | $45M | +109% |
| Q4 2025 | $16.6M | -51% |
| Q3 2025 | $37.4M | +$51.5M |
| Q2 2025 | -$2M | -113% |
| Q1 2025 | $21.5M | -61% |
| Q4 2024 | $33.7M | +$92.2M |
SBSI has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
SBSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +28K shares |
| 1 year | -0.8% | -230K shares |
| 3 years | -2.1% | -638K shares |
| 5 years | -8.1% | -2.7M shares |
| Available history | -12% | -4M shares |
SBSI has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $10.6M |
| Q3 2025 | $1.5M |
| Q4 2024 | $5,000 |
| Q3 2024 | — |
| Q2 2024 | $1.5M |
| Q1 2024 | — |
| Q4 2023 | $4.7M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
SBSI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -1.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -2.1x | Net Cash |
| Q1 2025 | -2.4x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
SBSI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like SBSI.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
SBSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.5 | Neutral |
| Stochastic | 77.9 | Neutral |
SBSI's weekly RSI is 62 (neutral) and its Stochastic is 78 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
SBSI PE vs Financial Services Sector
| Metric | SBSI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 27 | 63 | 36 pts below |
SBSI is trading at 11x earnings, a 19% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
SBSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.1 | 8.8% above |
| 20 week MA | $32.7 | 7% above |
| 50 week MA | $32.5 | 7.8% above |
| 100 week MA | $31.0 | 13% above |
| 200 week MA | $30.9 | 13% above |
SBSI has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
SBSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.1 | $31.3 | -15% |
| 2021 | $31.3 | $41.3 | +32% |
| 2022 | $41.3 | $35.5 | -14% |
| 2023 | $35.5 | $31.3 | -12% |
| 2024 | $31.3 | $31.8 | +1.6% |
| 2025 | $31.8 | $31.3 | -1.7% |
| 2026 YTD | $31.3 | $35.0 | +12% |
SBSI has the edge over IREN on returns for 2026, with the stronger performance.